TY - JOUR
T1 - Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer's subjects?
AU - Femminella, Grazia Daniela
AU - Livingston, Nicholas R
AU - Raza, Sanara
AU - van der Doef, Thalia
AU - Frangou, Eleni
AU - Love, Sharon
AU - Busza, Gail
AU - Calsolaro, Valeria
AU - Carver, Stefan
AU - Holmes, Clive
AU - Ritchie, Craig W
AU - Lawrence, Robert M
AU - McFarlane, Brady
AU - Tadros, George
AU - Ridha, Basil H
AU - Bannister, Carol
AU - Walker, Zuzana
AU - Archer, Hilary
AU - Coulthard, Elizabeth
AU - Underwood, Ben
AU - Prasanna, Aparna
AU - Koranteng, Paul
AU - Karim, Salman
AU - Junaid, Kehinde
AU - McGuinness, Bernadette
AU - Passmore, Anthony Peter
AU - Nilforooshan, Ramin
AU - Macharouthu, Ajayverma
AU - Donaldson, Andrew
AU - Thacker, Simon
AU - Russell, Gregor
AU - Malik, Naghma
AU - Mate, Vandana
AU - Knight, Lucy
AU - Kshemendran, Sajeev
AU - Tan, Tricia
AU - Holscher, Christian
AU - Harrison, John
AU - Brooks, David J
AU - Ballard, Clive
AU - Edison, Paul
PY - 2021/2/17
Y1 - 2021/2/17
N2 - BACKGROUND: Type 2 diabetes is a risk factor for Alzheimer's disease (AD), and AD brain shows impaired insulin signalling. The role of peripheral insulin resistance on AD aetiopathogenesis in non-diabetic patients is still debated. Here we evaluated the influence of insulin resistance on brain glucose metabolism, grey matter volume and white matter lesions (WMLs) in non-diabetic AD subjects.METHODS: In total, 130 non-diabetic AD subjects underwent MRI and [18F]FDG PET scans with arterial cannula insertion for radioactivity measurement. T1 Volumetric and FLAIR sequences were acquired on a 3-T MRI scanner. These subjects also had measurement of glucose and insulin levels after a 4-h fast on the same day of the scan. Insulin resistance was calculated by the updated homeostatic model assessment (HOMA2). For [18F]FDG analysis, cerebral glucose metabolic rate (rCMRGlc) parametric images were generated using spectral analysis with arterial plasma input function.RESULTS: In this non-diabetic AD population, HOMA2 was negatively associated with hippocampal rCMRGlc, along with total grey matter volumes. No significant correlation was observed between HOMA2, hippocampal volume and WMLs.CONCLUSIONS: In non-diabetic AD, peripheral insulin resistance is independently associated with reduced hippocampal glucose metabolism and with lower grey matter volume, suggesting that peripheral insulin resistance might influence AD pathology by its action on cerebral glucose metabolism and on neurodegeneration.
AB - BACKGROUND: Type 2 diabetes is a risk factor for Alzheimer's disease (AD), and AD brain shows impaired insulin signalling. The role of peripheral insulin resistance on AD aetiopathogenesis in non-diabetic patients is still debated. Here we evaluated the influence of insulin resistance on brain glucose metabolism, grey matter volume and white matter lesions (WMLs) in non-diabetic AD subjects.METHODS: In total, 130 non-diabetic AD subjects underwent MRI and [18F]FDG PET scans with arterial cannula insertion for radioactivity measurement. T1 Volumetric and FLAIR sequences were acquired on a 3-T MRI scanner. These subjects also had measurement of glucose and insulin levels after a 4-h fast on the same day of the scan. Insulin resistance was calculated by the updated homeostatic model assessment (HOMA2). For [18F]FDG analysis, cerebral glucose metabolic rate (rCMRGlc) parametric images were generated using spectral analysis with arterial plasma input function.RESULTS: In this non-diabetic AD population, HOMA2 was negatively associated with hippocampal rCMRGlc, along with total grey matter volumes. No significant correlation was observed between HOMA2, hippocampal volume and WMLs.CONCLUSIONS: In non-diabetic AD, peripheral insulin resistance is independently associated with reduced hippocampal glucose metabolism and with lower grey matter volume, suggesting that peripheral insulin resistance might influence AD pathology by its action on cerebral glucose metabolism and on neurodegeneration.
KW - Alzheimer’s disease
KW - Insulin resistance
KW - Magnetic resonance imaging
KW - Positron emission tomography imaging
U2 - 10.1186/s13195-021-00784-w
DO - 10.1186/s13195-021-00784-w
M3 - Article (Academic Journal)
C2 - 33597002
VL - 13
JO - Alzheimer's Research and Therapy
JF - Alzheimer's Research and Therapy
SN - 1758-9193
M1 - 47 (2021)
ER -